| Literature DB >> 31778276 |
Apoorva Safai1, Shweta Prasad2,3, Tanay Chougule1, Jitender Saini4, Pramod K Pal3, Madhura Ingalhalikar1.
Abstract
Microstructural changes associated with degeneration of dopaminergic neurons of the substantia nigra pars compacta (SNc) in Parkinson's disease (PD) have been studied using Diffusion Tensor Imaging (DTI). However, these studies show inconsistent results, mainly due to methodological variations in delineation of SNc. To mitigate this, our work aims to construct a probabilistic atlas of SNc based on a 3D Neuromelanin Sensitive MRI (NMS-MRI) sequence and demonstrate its applicability to investigate microstructural changes on a large dataset of PD. Using manual segmentation and deformable registration we created a novel SNc atlas in the MNI space using NMS-MRI sequences of 27 healthy controls (HC). We first quantitatively evaluated this atlas and then employed it to investigate the micro-structural abnormalities in SNc using diffusion MRI from 133 patients with PD and 99 HCs. Our results demonstrated significant increase in diffusivity with no changes in anisotropy. In addition, we also observed an asymmetry of the diffusion metrics with a higher diffusivity and lower anisotropy in the left SNc than the right. Finally, a multivariate classifier based on SNc diffusion features could delineate patients with PD with an average accuracy of 71.7%. Overall, from this work we establish a normative baseline for the SNc region of interest using NMS-MRI while the application on PD data emphasizes on the contribution of diffusivity measures rather than anisotropy of white matter in PD.Entities:
Keywords: Neuromelanin; Parkinson's disease; atlas; diffusion tensor imaging; substantia Nigra
Year: 2019 PMID: 31778276 PMCID: PMC7267920 DOI: 10.1002/hbm.24878
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
Review of articles that have performed diffusion MRI analysis on the substantia nigra pars compacta in Parkinson's disease
| Author (year) | Sample size (DTI/NM‐MRI) | ROI placement | ROI image | DTI results of PD in comparison to HC |
|---|---|---|---|---|
|
| ||||
| Langley et al. ( | 20:17/11 (PD: HC /HC) | Manual | NM‐T1, T2w | FA↓, MD↑ for NM‐T1 |
| Menke, Jbabdi, Miller, Matthews, and Zarei ( | 10:10 (PD: HC) | Semiautomatic | T1w, DTI tracks | No significance |
|
| ||||
| Schwarz et al. ( | 32:27 (PD: HC) | Manual | T2w | MD↑ |
| Du et al. ( | 16:16 (PD: HC) | Semiautomatic | T2w | FA↓, R2*↑ |
| Prakash et.al ( | 11:12 (PD: HC) | Manual | T2w | FA asymmetry in SNc subregion in PD |
| Rolheiser et al. ( | 14:14 (PD: HC) | Manual | T2w + V1 maps | FA↓, RD↑ |
| Peran et al. ( | 30:22 (PD: HC) | Manual | T2*w images | FA↓, R2*↑ |
| Vaillancourt et al. ( | 14:14 (PD: HC) | Manual | T2w | FA↓ |
|
| ||||
| Knossalla et al. ( | 10:10 (PD: HC) | Manual | FA maps | FA↓ |
| Asymmetry in SNc subregion | ||||
| Loane et al. ( | 18:14 (PD:HC) | Manual | FA, MD maps | FA↓, MD↑ |
| Schuff et al ( | 67:153 (PD:HC) | Manual | FA maps, T1w | FA↓ in rostral SNc, AD↑, RD |
| No significance | ||||
| Aquino et al. ( | 42:20 (PD:HC) | Manual | Axial IR | No significance |
| Zhan et al. ( | 12:20 (PD:HC) | Semiautomatic | FA maps | FA↓ |
| Gattellaro et al. ( | 10:10 (PD:HC) | Manual | DTI tracks | No significance |
| Chan et al. ( | 73:78 (PD:HC) | Manual | FA maps | FA↓ |
Abbreviations: ↑: Increase; ↓: Decrease; DTI: Diffusion Tensor Imaging; FA: Fractional Anisotropy; HC: Healthy Controls; MD: Mean Diffusivity; NM‐MRI: Neuromelanin Magnetic Resonance Imaging; NM‐T1: Neuromelanin sensitive T1; PD: Parkinson's disease; RD: Radial Diffusivity; ROI‐Region Of Interest; SNc: Substantia Nigra pars compacta; T1w: T1 weighted; T2w: T2 weighted.
Figure 1(a) Schematic for probabilistic atlas construction of substantia nigra in MNI space with thresholding. i: ith subject; n: number of subjects; tx1: transformation matrix of NMS‐MRI to T1 registration, tx2: transformation matrix of T1 to MNI registration. (b) Probabilistic and thresholded substantia nigra atlas in subject space
Demographic and clinical characteristics of patients with Parkinson's disease and healthy controls
| Parkinson's disease ( | Healthy controls ( |
| |
|---|---|---|---|
| Gender (M: F) | 104:29 | 71:28 | 0.257 |
| Age | 54.19 ± 8.23 | 52.34 ± 7.94 | .08 |
| Age at onset | 48.70 ± 9.36 | — | NA |
| Duration of illness | 5.08 ± 3.11 | — | NA |
| MMSE | 27.22 ± 2.51 | — | NA |
| UPDRS III (OFF score) * | 34.68 ± 8.80 | — | NA |
| LEDD | 598.39 ± 238.50 | — | NA |
Abbreviations: F: Female; LEDD: Levodopa equivalent daily dose; M: Male; MMSE: Mini mental status examination; UPDRS: Unified Parkinson's disease rating scale, *: UPDRS III (OFF score) was available for 110 subjects.
Figure 2(a) Boxplot of dice coefficient scores amongst raters (b) Boxplot of dice coefficient scores between SNc atlas in subject space and all three raters. Light gray indicates left SNc and dark gray indicates right SNc
Figure 3Results of independent t test indicating differences in diffusion measures of bilateral substantia nigra in Parkinson's patient and healthy controls. Blue boxplot indicates healthy controls group whereas orange indicates PD patients group. NS: not significant, * p < .05, ** p < .005, *** p < .0005
FDR corrected (p‐value = .05) results of independent t test for diffusion measures between healthy controls and patients with Parkinson's disease
| PD | HC |
|
|
| |
|---|---|---|---|---|---|
| Variable | (mean ± | (mean ± | (PD vs HC) | (PDL vs PDR) | (HCL vs HCR) |
| ADL | 1.17 × 10−3 ± 6.94 × 10−5 | 1.13 × 10−3 ± 6.76 × 10−5 | .00002 | 4.67e‐16 | 1.43e‐07 |
| ADR | 1.1 × 10−3 ± 5.76 × 10−5 | 1.08 × 10−3 ± 5.93 × 10−5 | .0178 | — | — |
| FAL | 4.06 × 10−1 ± 2.59 × 10−2 | 4.03 × 10−1 ± 3.07 × 10−2 | .5149 | 1.24e‐04 | 4.13e‐03 |
| FAR | 4.19 × 10−1 ± 2.96 × 10−2 | 4.17 × 10−1 ± 3.35 × 10−2 | .5149 | — | — |
| MDL | 8.21 × 10−4 ± 5.12 × 10−5 | 7.89 × 10−4 ± 4.48 × 10−5 | .0000 | 2.32e‐19 | 1.57e‐13 |
| MDR | 7.63 × 10−4 ± 4.45 × 10−5 | 7.42 × 10−4 ± 3.64 × 10−5 | .0002 | — | — |
| RDL | 6.49 × 10−4 ± 4.72 × 10−5 | 6.21 × −4 ± 3.91 × 10−5 | .0000 | 5.48e‐19 | 4.68e‐15 |
| RDR | 5.95 × 10−4 ± 4.27 × 10−5 | 5.76 × −4 ± 3.36 × 10−5 | .0002 | — | — |
Abbreviations: AD: Axial diffusivity; ADL: AD of left SNc, ADR: AD of right SNc; FA: Fractional anisotropy; FAL: FA of left SNc; FAR: FA of right SNc; HC: Healthy controls; HCL: Left SNc of HC; HCR: Right SNc of HC; MD: Mean diffusivity; MDL: MD of left SNc; MDR: MD of right SNc; PD: Parkinson's disease; PDL: Left SNc of patients with PD, PDR: Right SNc of patients with PD; RD: Radial diffusivity; RDL: RD of left SNc, RDR: RD of right SNc; SD: Standard deviation; SNc: Substantia nigra pars compacta.
Figure 4ROC plots for random forest classifiers